Recalls for Igg (fd Fragment Specific), Antigen, Antiserum, Control

1 on file

Roche Diagnostics Corporation
TerminatedApr 13, 2019
New endogenous interference claims have been established for the following assays used on the cobas c 311 analyzer and the cobas c 501, 502, 701, 702, and Modular Analytics P/D modules which may have potential medical risk. ***Update: Cobas c111 and COBAS INTEGRA 400 plus analyzers are also impacted for BILT3 and LACT2 assays***